MarketCap
Facebook
X
TelegramAnnual report 2022
added 08-16-2022
Global Cord Blood Corporation DIO Ratio 2011-2025 | CO
Annual DIO Ratio Global Cord Blood Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 89.7 | 89.8 | 68.9 | 54.2 | 55.7 | 79.3 | 71.5 | 66.5 | 109 | 35.1 | 28.1 | 31.7 |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 109 | 28.1 | 64.9 |
Quarterly DIO Ratio Global Cord Blood Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 33.4 | - | - | - | 57.3 | - | - | - | 25.9 | - | - | - | 31.4 | - | - | - | 38.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 46 | 39.2 | - | - | 18 | 23 | 30.9 | 42 | 22.8 | 15.4 | - |
All numbers in CNY currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 57.3 | 15.4 | 32.6 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
243 | $ 20.31 | -5.8 % | $ 221 M |  China |
 |
Co-Diagnostics
CODX
|
304 | $ 0.23 | -4.17 % | $ 6.75 M | USA |
 |
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
48.7 | $ 39.2 | -0.49 % | $ 1.09 B | USA |
 |
Danaher Corporation
DHR
|
92.9 | $ 230.87 | 0.23 % | $ 169 B | USA |
 |
DarioHealth Corp.
DRIO
|
165 | $ 10.36 | 3.19 % | $ 294 M |  Israel |
 |
BioNano Genomics
BNGO
|
245 | $ 1.51 | -0.9 % | $ 1.92 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M |  Britain |
 |
Exact Sciences Corporation
EXAS
|
240 | $ 101.86 | 0.28 % | $ 18.9 B | USA |
 |
DexCom
DXCM
|
119 | $ 67.65 | 0.12 % | $ 26.1 B | USA |
 |
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
7.17 | $ 26.63 | -0.34 % | $ 805 M | USA |
 |
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
48.3 | $ 19.19 | -1.49 % | $ 1.03 B | USA |
 |
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | USA |
 |
Guardant Health
GH
|
78.4 | $ 100.93 | -1.99 % | $ 12.4 B | USA |
 |
Aspira Women's Health
AWH
|
23.1 | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
35.8 | $ 6.32 | -2.55 % | $ 573 M | USA |
 |
ENDRA Life Sciences
NDRA
|
405 | $ 4.75 | -4.81 % | $ 2.55 M | USA |
 |
Neogen Corporation
NEOG
|
147 | $ 7.2 | 0.98 % | $ 1.56 B | USA |
 |
Illumina
ILMN
|
137 | $ 134.56 | -0.29 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
35.3 | $ 203.33 | -0.11 % | $ 10.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
10.4 | $ 175.36 | -0.34 % | $ 19.5 B | USA |
 |
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K | Israel |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 27.26 | 0.57 % | $ 20 B |  Niderland |
 |
Laboratory Corporation of America Holdings
LH
|
18.8 | $ 252.95 | -0.4 % | $ 21.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
0.213 | $ 182.75 | -0.05 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
91.6 | $ 685.99 | -0.36 % | $ 56.6 B | USA |
 |
Lantheus Holdings
LNTH
|
44.2 | $ 67.0 | 0.43 % | $ 4.64 B | USA |
 |
Personalis
PSNL
|
12.1 | $ 8.01 | -1.6 % | $ 475 M | USA |
 |
Mettler-Toledo International
MTD
|
79 | $ 1 419.41 | -0.06 % | $ 30.1 B |  Schweiz |
 |
Agilent Technologies
A
|
97.1 | $ 138.09 | -0.22 % | $ 42 B | USA |
 |
Quidel Corporation
QDEL
|
133 | $ 29.27 | -0.12 % | $ 1.23 B | USA |
 |
Biomerica
BMRA
|
147 | $ 2.6 | -3.7 % | $ 5.97 M | USA |